Hyperfine, Inc. (NASDAQ:HYPR) Q4 2022 Earnings Call Transcript

Maria Sainz: Sure. So yes, we have had feedback. Don’t know if you know, but usually we do a data release and get about two or three dozen cases done before we actually submit our 510(k). So we have some inputs from the data runs and then we have now a little bit of run time. Clearly, a lot of positive as to where we’ve taken DWI. There is a general field of immense progress in the last two years on that level of imaging. As you think forward, continue to do €“ to improve our DWI, also because we have that appetite to get into stroke, and that’s going to be critical. There’s some other things that we can do to continue to strengthen the robustness to motion, the correction for noise through more DL and then some other features around usability.

We’re looking at software helping with the patient position, which is also important and other things like that. What I would say is that these improvements are getting us closer and closer to feeling really ready to take on the ischemic stroke setting and as such is probably going to be after the next software release, probably when we feel ready to start that Action PMR study that we have discussed.

Neil Chatterji: Great! Thanks. That’s it from me.

Operator: Thank you. I’m showing no further questions at this time. I’ll turn the call back over to Maria Sainz, Chief Executive Officer for any closing remarks.

Maria Sainz : Thank you. We remain very bullish about the Hyperfine opportunity, and we feel we have taken the measures necessary to establish a strong foundation to deliver on the three pillars that I have outlined. I want to thank you for your interest in Hyperfine and look forward to updating all of you again in May. Thank you.

Operator: Thank you. Ladies and gentlemen, this does conclude today’s conference. Thank you all for participating. You may now disconnect. Have a great day!